Proportion detected by screening mammography (%) | Pvalue | |
---|---|---|
All patients * | 196/587 (33.4%) | - |
HER-2 negative | 180/516 (34.9%) | |
HER-2 positive | 16/71 (22.5%) | 0.039 |
ER positive | 191/536 (35.6%) | |
ER negative | 5/51 (9.8%) | < 0.0001 |
PR positive | 171/460 (37.2%) | |
PR negative | 25/102 (19.7%) | < 0.0001 |
Triple negative | 4/32 (12.5%) | |
Non-triple negative | 192/555 (34.6%) | 0.100 |